5:54 PM
Sep 10, 2013
 |  BC Extra  |  Politics & Policy

Bill would overhaul India's drug approval authority

A bill introduced in the upper house of the Indian parliament would establish the Central Drugs Authority (CDA) and centralize licensing for 17 categories of drugs and therapeutics, including vaccines, mAbs and cell therapy, stem cell or gene therapy products. Under the bill, the existing Central Drug Standard Control Organization...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >